• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.新型冠状病毒肺炎（COVID-19）大流行期间重症肌无力（MG）和兰伯特-伊顿肌无力综合征（LEMS）的管理指南。
J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.
2
Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.重症肌无力和兰伯特-伊顿肌无力综合征的治疗。
Semin Neurol. 2003 Jun;23(2):191-8. doi: 10.1055/s-2003-41135.
3
COVID-19 in patients with myasthenia gravis.COVID-19 与重症肌无力。
Muscle Nerve. 2020 Aug;62(2):254-258. doi: 10.1002/mus.26918. Epub 2020 May 22.
4
Description of 3 patients with myasthenia gravis and COVID-19.描述 3 例重症肌无力和 COVID-19 患者。
J Neurol Sci. 2020 Oct 15;417:117053. doi: 10.1016/j.jns.2020.117053. Epub 2020 Jul 22.
5
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.新型冠状病毒肺炎与重症肌无力全身型加重：一例报告
Clin Neurol Neurosurg. 2020 Sep;196:106045. doi: 10.1016/j.clineuro.2020.106045. Epub 2020 Jun 25.
6
Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.临床推理：新型冠状病毒肺炎感染所致重症肌无力危象的治疗考量
Neurology. 2020 Nov 3;95(18):840-843. doi: 10.1212/WNL.0000000000010651. Epub 2020 Aug 14.
7
Management of patients with generalised myasthenia gravis and COVID-19: four case reports.全身型重症肌无力合并新型冠状病毒肺炎患者的管理：4例病例报告
J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1124-1125. doi: 10.1136/jnnp-2020-323565. Epub 2020 Jul 10.
8
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.COVID-19 合并难治性重症肌无力：成功治疗 1 例报告
J Neuromuscul Dis. 2020;7(3):361-364. doi: 10.3233/JND-200520.
9
Myasthenic crisis in COVID-19.新冠病毒相关性肌无力危象。
J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6.
10
How to manage rheumatic patients during the coronavirus pandemic.如何在新冠疫情期间管理风湿病患者。
Panminerva Med. 2020 Sep;62(3):176-177. doi: 10.23736/S0031-0808.20.03935-X. Epub 2020 Apr 28.

引用本文的文献

1
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19.血清促炎细胞因子、核因子 κB 受体激活剂配体（RANKL）、骨保护素（OPG）及 RANKL/OPG 比值在轻症和重症 COVID-19 中的变化。
BMC Infect Dis. 2024 Sep 27;24(1):1047. doi: 10.1186/s12879-024-09941-6.
2
Clinical features of COVID-19 infection in patients with myasthenia gravis: a real-world retrospective study.新冠病毒感染合并重症肌无力患者的临床特征：一项真实世界的回顾性研究。
Front Public Health. 2024 Aug 27;12:1421211. doi: 10.3389/fpubh.2024.1421211. eCollection 2024.
3
Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis.重症肌无力与2019冠状病毒病：一项系统评价与荟萃分析
Basic Clin Neurosci. 2024 Mar-Apr;15(2):175-184. doi: 10.32598/bcn.2023.4360.5. Epub 2024 Mar 1.
4
Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients.重症肌无力患者回顾性队列中与COVID-19相关的不良预后预测因素
J Inflamm Res. 2024 Aug 29;17:5807-5820. doi: 10.2147/JIR.S475729. eCollection 2024.
5
Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers - An updated European Academy of Neurology consensus statement.考虑到大流行后 2019 年冠状病毒病（COVID-19）相关风险和危害的神经疾病患者管理-欧洲神经病学会更新的共识声明。
Eur J Neurol. 2024 Oct;31(10):e16408. doi: 10.1111/ene.16408. Epub 2024 Aug 1.
6
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.齐卢可普兰治疗全身型重症肌无力患者的长期安全性和有效性：RAISE-XT开放标签扩展研究的中期分析
Ther Adv Neurol Disord. 2024 Apr 17;17:17562864241243186. doi: 10.1177/17562864241243186. eCollection 2024.
7
Myasthenia gravis and coronavirus disease 2019: A report from Iran.重症肌无力与2019冠状病毒病：来自伊朗的报告。
Curr J Neurol. 2021 Jul 6;20(3):162-165. doi: 10.18502/cjn.v20i3.7692.
8
Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study.中国广西重症肌无力合并新型冠状病毒肺炎患者的临床特征：一项病例对照研究
J Inflamm Res. 2023 Jul 26;16:3157-3168. doi: 10.2147/JIR.S419307. eCollection 2023.
9
Health-related quality of life (HRQoL) and psychological impact of the COVID-19 pandemic on patients with myasthenia gravis.2019年冠状病毒病大流行对重症肌无力患者与健康相关的生活质量及心理影响
Intractable Rare Dis Res. 2023 May;12(2):88-96. doi: 10.5582/irdr.2023.01003.
10
Neuromuscular Disorders Associated With COVID-19.与新型冠状病毒肺炎相关的神经肌肉疾病
Neurosci Insights. 2023 May 25;18:26331055231176251. doi: 10.1177/26331055231176251. eCollection 2023.

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.

作者信息

Jacob Saiju, Muppidi Srikanth, Guidon Amanda, Guptill Jeffrey, Hehir Michael, Howard James F, Illa Isabel, Mantegazza Renato, Murai Hiroyuki, Utsugisawa Kimiaki, Vissing John, Wiendl Heinz, Nowak Richard J

机构信息

Department of Neurology, Institute of Immunology and Immunotherapy, University Hospitals, Birmingham B15 2TH, United Kingdom.

Department of Neurology, Stanford Neuroscience Health Center, Palo Alto, CA 94304, USA.

出版信息

J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.

DOI:10.1016/j.jns.2020.116803
PMID:32247193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7105910/
Abstract
摘要